More years of mobility and independence, and fewer prolonged periods of illness later in life, is certainly alluring, but is it attainable?

Longevity research has evolved from ancient myths, like Emperor Qin Shi Huang's quest for an elixir, into a multi-billion dollar scientific pursuit driven by tech billionaires and global powers ...

A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in the human eye. The study, called ER-100, uses a gene therapy vector to ...

Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have treated the first participant in a clinical trial exploring whether older cells ...

For decades, reversing ageing has belonged more to the realm of science fiction than modern medicine. Researchers could slow aging in laboratory animals, extend lifespan in worms and mice, and ...

Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

Aging—the progressive decline in our physiological function as we get older—is something many of us hope to slow, stop, or even reverse. Of course, this process is inevitable and something we cannot ...

For most of medical history, aging has been treated as a kind of slow damage accumulation, the body accruing wear the way a car does. A small army of researchers is now making a different argument, ...

First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...